Andrew R Allen Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Andrew R Allen.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Andrew R Allen. Andrew R Allen is a Chief Medical Officer, EVP in PHARMION CORP ($PHRM) and a Director in Sierra Oncology, Inc. ($SRRA) and a See Remarks in Clovis Oncology, Inc. ($CLVS) and a Director in Epizyme, Inc. ($EPZM) and a President and CEO in Gritstone Oncology, Inc. ($GRTS) and a Director in TCR2 THERAPEUTICS INC. ($TCRR).

Address: 2525 28TH STREET SUITE 200 BOULDER 80301 CO

Companies in which Andrew R Allen is an Insider

Clovis Oncology, Inc.

Trading Symbol: CLVS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Andrew R Allen: See Remarks
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 04 2015
$CLVS Market Capitalization: $2.45B
$CLVS Previous Close: $60.00

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Epizyme, Inc.

Trading Symbol: EPZM
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Andrew R Allen: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 07 2019
$EPZM Market Capitalization: $707.73M
$EPZM Previous Close: $12.05

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Gritstone Oncology, Inc.

Trading Symbol: GRTS
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Andrew R Allen: President and CEO
Holdings: 0 shares
Latest Transaction: Mar 14 2019

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

PHARMION CORP

Trading Symbol: PHRM
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Andrew R Allen: Chief Medical Officer, EVP
Holdings: 0 shares
Latest Transaction: Mar 12 2008

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Sierra Oncology, Inc.

Trading Symbol: SRRA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Andrew R Allen: Director
Holdings: 66,000 shares
Latest Transaction: Jun 12 2019

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 1x
Sell: 0x
Shares Bought: 66,000
Shares Sold: 0
Share Difference: +66,000
Value Difference: -$108,240

TCR2 THERAPEUTICS INC.

Trading Symbol: TCRR
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Andrew R Allen: Director
Holdings: 0 shares
Latest Transaction: Apr 12 2019

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Andrew R Allen

Sentiment: All, CLVS, EPZM, GRTS, PHRM, SRRA, TCRR

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 12 2019SRRASierra Oncology, I ...Allen Andrew RDirectorOption ExerciseA0.6630,00019,80030,000
Jun 07 2019EPZMEpizyme, Inc.Allen Andrew RDirectorOption ExerciseA13.7417,633242,27717,633
Apr 12 2019TCRRTCR2 THERAPEUTICS ...Allen Andrew RDirectorOption ExerciseA16.116,270101,0106,270
Mar 14 2019GRTSGritstone Oncology ...Allen Andrew RPresident and CEOOption ExerciseA12.02180,0002,163,600180,000
Dec 11 2018SRRASierra Oncology, I ...Allen Andrew RDirectorBuyP1.6466,000108,24066,0000 to 66 K
Jun 14 2018SRRASierra Oncology, I ...Allen Andrew RDirectorOption ExerciseA3.2725,00081,75025,000
May 31 2018EPZMEpizyme, Inc.Allen Andrew RDirectorOption ExerciseA17.0012,500212,50012,500

View all Andrew R Allen insider transactions.